The company may no longer be operating, as it has been acquired. Find out why through their latest events.
Tryp Therapeutics Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Jason Carroll
Chief executive officer
n/a
Total compensation
CEO salary percentage
n/a
CEO tenure
less than a year
CEO ownership
n/a
Management average tenure
1.7yrs
Board average tenure
3.3yrs
Recent management updates
Recent updates
CEO
Jason Carroll
less than a year
Tenure
Mr. Jason Carroll serves as Chief Executive Officer of Tryp Therapeutics Inc. since October 01, 2023 and serves as its Director. He has a wealth of experience as a highly regarded life sciences executive,...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
James Kuo
Co-Founder & Director
no data
CA$26.67k
6.22% $ 262.8k
Peter Molloy
Chief Business Officer & Director
less than a year
CA$183.59k
0.21% $ 8.8k
Jason Carroll
CEO & Director
less than a year
no data
no data
James Gilligan
President & Chief Scientific Officer
3.5yrs
CA$315.87k
no data
William Garner
Founder & MD
no data
CA$56.43k
39.85% $ 1.7m
Jim O'Neill
Chief Financial Officer
1.7yrs
no data
no data
Sidney Taubenfeld
Chief Operating Officer
1.9yrs
CA$48.70k
no data
Joy Willis
Director of Investor Relations
2.7yrs
no data
no data
Michael Silverman
Chief Medical Officer
1.4yrs
no data
no data
1.7yrs
Average Tenure
58yo
Average Age
Experienced Management: TRYP.F's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
Board Members
Name
Position
Tenure
Compensation
Ownership
James Kuo
Co-Founder & Director
4.7yrs
CA$26.67k
6.22% $ 262.8k
Peter Molloy
Chief Business Officer & Director
no data
CA$183.59k
0.21% $ 8.8k
Jason Carroll
CEO & Director
no data
no data
no data
William Schmidt
Member of Scientific Advisory Board
3.3yrs
no data
no data
P. Jull
Independent Chairman of the Board
3.7yrs
CA$26.67k
0.48% $ 20.3k
Christopher Ntoumenopoulos
Independent Non Executive Director
2yrs
no data
no data
Daniel Clauw
Member of Scientific Advisory Board
2.8yrs
no data
no data
Robin Carhart-Harris
Chairman of Scientific Advisory Board
3.3yrs
no data
no data
Rachel Wevrick
Member of Scientific Advisory Board
no data
no data
no data
Derek Ott
Member of Scientific Advisory Board
no data
no data
no data
Joel Castellanos
Member of Scientific Advisory Board
3.3yrs
no data
no data
3.3yrs
Average Tenure
58yo
Average Age
Experienced Board: TRYP.F's board of directors are considered experienced (3.3 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2024/05/02 23:28
End of Day Share Price
2024/05/02 00:00
Earnings
2024/02/29
Annual Earnings
2023/08/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Entropy Neurodynamics Limited is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.